Modulation of DNA synthesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was studied in primary cultures of hepatocytes and in rat liver epithelial cells (WB-F344) to develop models for studies on the interactions between the activated Ah receptor and cellular growth control. In hepatocytes TCDD either positively or negatively modulated EGF-stimulated DNA synthesis. In the presence of ethinylestradiol 10" 12 M TCDD moderately increased EGFstimulated DNA synthesis (-30%). In contrast, 10~9 M TCDD in the absence of ethinylestradiol decreased DNA synthesis (-30%). Analysis of variance revealed that the TCDD effects were highly significant The response of 'early genes' of the jun/fos family and the corresponding proteins was also studied under these two conditions. In agreement with the DNA synthesis data, the level of c-Jun was increased or decreased in nuclear extracts. Furthermore, DNA binding of Jun/Fos proteins, including c-Jun and Fra-1, was decreased under conditions of mitoinhibition, while the level of Fra-1 in nuclear extracts was increased. In WB-F344 cells TCDD treatment for 44 h increased DNA synthesis 2-to 3-fold in comparison with controls, based on measuring [ 3 H]thymidine incorporation into DNA or on determining the nuclear labeling index with bromodeoxyuridine. This effect is probably due to inhibition of high density growth arrest by TCDD. The proposed cellular models may be useful to elucidate the interactions between the activated Ah receptor and signaling pathways of growth homeostasis.
Introduction
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD*), the prototype of a group of ubiquitous environmental pollutants, is known to: (i) induce a battery of drug metabolizing enzymes in vertebrates; (ii) alter proteins involved in the control of growth and differentiation; (iii) produce tissue-and species-dependent toxic reactions, such as chloracne, immunosuppression, teratogenicity and carcinogenicity (1-7). Hepatocarcinogenesis by TCDD is considered to be due to its tumour promoting action (8) . Most TCDD-induced toxic reactions are believed to be initiated by activation of the Ah receptor (also termed die
•Abbreviations: TCDD, 23,7,8-tetrachlorodibenzo-p-dioxin; EGF, epidermal growth factor, EE, ethinylestradiol; dT, [ 3 H]thymidine; DMEM, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; BrdU, 5-bromo-2'-deoxyuridine; DMSO, dimethylsulfoxide; EROD, ethoxyresorufin 0-deethylase; PMSF, phenylmethylsulfonyl fluoride; DTT, dithiothreitol; AP-1, activator protein-1; PBS, phosphate-buffered saline. dioxin receptor). The receptor, which is expressed in most vertebrate tissues, has recently been characterized as a member of the basic helix-loop-helix/Per-Arnt-Sim transcription factors (9) (10) (11) . Persistent activation of the Ah receptor probably leads to alterations in cellular growth control in target tissues. However, molecular mechanisms linking Ah receptor activation and alterations in growth homeostasis are presently unknown.
Previous studies indicated that TCDD treatment of rat and mouse hepatocytes leads to positive or negative modulation of epidermal growth factor (EGF)-stimulated DNA synthesis (12) (13) (14) . Dual effects have also been reported in vivo in different zones of the liver lobule (15) . Whereas TCDD stimulated DNA synthesis in periportal hepatocytes, mitoinhibition by TCDD was preponderant in the rest of the liver lobule. Primary hepatocytes respond to mitogens such as EGF by entering Gj from the G o phase of the cell cycle (16) . DNA synthesis starts after 20-24 h, when the cells enter S phase. The latter reaction was used as the biological end-point for growth control in the present study (Figure 1 ). The response to EGF has been shown to be modulated by many factors, for example by estrogens (17, 18) and by TCDD (13, 19) . The present study was undertaken to better define die conditions under which TCDD positively or negatively modulates EGFstimulated DNA synthesis. The response of 'early' protooncogenes of the jun/fos family and the corresponding proteins was also studied under diese conditions. Jun/Fos proteins are known to be regulated by both transcriptional activation and by post-translational protein phosphorylation (20, 21) .
Hepatocytes isolated from periportal and perivenous zones of the liver lobule respond differently to growth factors (22) . Hence, effects in a mixed population of hepatocytes are expected to be low, since only a small fraction of cells responds to mitogens. Therefore, growth modulation by TCDD was also studied in a rat epithelial cell line (WB-F344). This cell line has been reported to respond to TCDD by increased CYP1A1 activity and DNA synthesis (23) . The described models may be useful to elucidate die molecular mechanisms linking Ah receptor activation with altered growth control.
Materials and methods

Chemicals
Reagents were obtained from the following sources: TCDD from Okometric (Bayreuth, Germany); insulin, dexamethasone, ethinylestradiol (EE) and proteinase inhibitors from Sigma (Deisenhofen, Germany); [ 3 H]thvmidine (dT) from Amersham BuchJer (Braunschweig, Germany); Dulbecco's modified Eagle's medium (DMEM) and gentamicin sulfate from Biochrom (Berlin, Germany); Waymouth MD 705/1 medium, fetal calf serum (FCS) and penicillin/streptomycin from Gibco (Eggenstein, Germany); Richter's IMEMZO medium from Biochrom (Berlin, Germany) or c.c.pro GmbH (Neustadt, Germany); ITS/rrS + from Collaborative Biomedical Products (Bedford, MA). Mouse EGF, poly(dl-dC), ethoxyresorufin and anti-mouse horseradish peroxidase-labeled antibodies were obtained from Boehringer (Mannheim, Germany). Antibodies against c-Jun, JunB, c-Fos and Fra-1 were from Santa Cruz Biotechnology (Santa Cruz, CA), mouse monoclonal anti-5-bromo-2'-deoxyuridine (BrdU) antibody and horseradish peroxidase-labeled swine anti-rabbit IgG antibodies from Dako (Hamburg, Germany). 
Hours
"The experimental protocol is listed in Figure 1 .
•"Relative dT incorporation (ratio of dT incorporation in the presence and absence of EGF) in the absence of TCDD treatment was taken as 100%, as described in Materials and methods. Note that in EE-treated cultures dT incorporation was ~2-fold higher (range 1.5-2.6). 
Cell culture and treatment
Primary hepatocytes from male Wistar rats (220-250 g) were isolated by recirculating collagenase perfusion in situ (24) . Cell viability, measured by trypan blue exclusion, was >80%. Cells were suspended in DMEM/ Waymouth medium (1:1) supplemented with 10 mM HEPES buffer, pH 7.4, 5X10"" 8 M dexamethasone, ITS (containing 5 Hg/ml insulin, 5 ng/ml transferrin and 5 ng/ml selenous acid), 10% FCS and 50 Hg/ml gentamicin. Hepatocytes were seeded on 9 cm Petri dishes covered with rat tail collagen at a density of 20 000 cells/cm 2 . After 3 h in culture the medium was changed to serum-free conditions (25) , ITS and FCS being replaced by ITS + containing 6.25 |ig/ml insulin, 6.25 Hg/ml transferrin, 6.25 ng/ml selenous acid, 1.25 mg/ml bovine serum albumin and 5.35 ng/ml linoleic acid. TCDD (10) (11) (12) or lCT 9 M), EE (20 nM) and EGF (20 ng/ml) were added at the time points indicated in Figure 1 . TCDD and EE were dissolved in dimethylsulfoxide (DMSO); controls contained only the solvent. The final concentration of DMSO was <0.1 %.
WB-F344 cells were grown up to passages 16-22 in Richter's medium containing 10% FCS. Cells were seeded on 9 cm Falcon plates at a density of -200 000 cells/plate in Richter's IMEMZO medium supplemented with 20 mM HEPES, 10% FCS, 2 mM glutamine, 50 ng/ml gentamicin and 4 ng/ ml insulin. Cells were kept at 37°C in a humidified atmosphere of 5% CO 2 in air and the medium was changed every second day. When the cells reached confluency the medium was changed and 24 h later they were treated with TCDD. After 2 h the medium was changed to serum-free medium, Richter's IMEMZO medium supplemented with ITS + .
CYP1A activity and DNA synthesis CYP1A activity was determined by ethoxyresorufin 0-deethylase (EROD) assay in cell homogenates as described (26) . Protein was determined according to Lowry et aL (27) . DNA was determined according to Burton (28) . Table I ). DNA was extracted and dT incorporation was measured as described (13) . As an example of data analysis (Table I) in group 1, consisting of four experiments (+10~1 2 M TCDD+EE), the following data (c.p.miu.g DNA ± SD) were obtained (for each experiment data represent means of four determinations): (A) -EGF, -TCDD, 5609 ± 3274; (B) +EGF, -TCDD, 9533 ± 4576; (Q +EGF, +TCDD, 11911 ± 5130 (dT incorporation between 21 and 29 h -EGF was found to be 427 ± 257). Because of high daily variation in dT incorporation the ratios B:A (1.85 ± 0.35, set as 100%) and C:A (2.37 ± 0.70) were used for calculations and for analysis of variance in Table I . Note that the B:A and C:A ratios differed for groups 1-4. Note also that in the presence of EE (groups 1 and 2) dT incorporation was ~2-fold higher (range 1.5-2.6). For WB cells dT incorporation was measured similarly, but the labeling period was 2 h.
BrdU labeling index.
BrdU incorporation into nuclei of WB cells was determined in 10-well multitest slides on which the cells were grown. After reaching confluency the cells were treated with 10~9 M TCDD. The medium containing 10% FCS was changed to serum-free conditions after 2 h. After 46 h cells were labeled with 80 nM BrdU for 2 h. Slides were fixed in methanol:acetone (1:1) for 3 min and air dried. DNA was denatured in 4 M HC1 for 15 min at room temperature. Thereafter the slides were treated with hematoxylin for 5 min, with mouse anti-BrdU antibody and with anti-mouse horseradish peroxidase-labeled antibody followed by 3,3-diaminobenzidine staining. After dehydration in ethanol and xylene the slides were coverslipped with Entellan (Merck, Darmstadt, Germany) and the number of BrdU-labeled nuclei was counted. The labeling index was calculated as the number of BrdU-positive cells/100 cells. The labeling index was analyzed in randomly chosen fields, 1000-1500 cells being counted per experiment.
Preparation of hepatocyte plasma membranes and EGF receptor autophosphorylation
Plasma membranes were prepared as described (29) . All buffer solutions (pH 7.4) contained 20 mM HEPES, 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and 1 mM EDTA. Plasma membranes (10 mg protein/ml) were stored at -80°C. Phosphorylation of plasma membrane proteins (50 ng) was carried out using 15 uM [-)<- 32 P]ATP (3000 Ci/mmol; Amersham Buchler) with and without EGF (20 ng/ml). After SDS-PAGE the gels were stained with Coomassie blue, dried and autoradiographed at 4°C using an intensifying screen.
Nuclear extracts
Nuclear extracts from primary hepatocytes were prepared 2 h after addition of EGF, as described (30) . Hepatocytes were washed twice with ice-cold 0.9% NaCl, harvested and pelleted by centrifugation for 5 min at 250 g. The cell pellet was resuspended in 5 vol. buffer A [10 mM HEPES, pH 7.6, 1.5 mM MgCl 2 . 10 mM KC1, 0.5 mM dithiothreitol (DTT) and proteinase inhibitors: 0.25 mM PMSF, 0.5 mM benzamidine, 5 ng/ml aprotinin, 5 \ig/m\ leupeptin and 2 ng/ml pepstatin A]. The cell suspension was centrifuged for 5 min at 250 g and the pellet resuspended in 3 vol. buffer A. After addition of 0.5% Triton X-100 the cells were homogenized with a Dounce homogenizer (30 strokes). The homogenate was centrifuged at 500 g and the pelleted nuclei resuspended in 3 vol. buffer B (5 mM HEPES, 26% glycerol, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT and the proteinase inhibitors of buffer A). After adding KC1 to a final concentration of 400 mM nuclear proteins were extracted for 30 min on ice and centrifuged at 100 000 g for 20 min. Nuclear extracts were stored at -80°C. Protein was determined according to Bradford (31) .
Gel retardation analysis DNA binding was studied using a 26 bp oligonucleotide containing the activator protein-1 (AP-I) binding site of the human collagenase promoter (32) . This oligonucleotide (5'-GTTATAAAGCATGAGTCAGACACCTC-3') was synthesized by MWG-Biotech (Ebersberg, Germany). After annealing the oligonucleotide (-5 pmol) was end-labeled with [-y- 32 P]dATP using T4 polynucleotide kinase. Unincorporated nucleotides were separated using Nick spin columns (Pharmacia, Uppsala, Sweden). The reaction mixture for the binding assay consisted of 25 mM HEPES, pH 7.9, I mM EDTA, 10% glycerol, 1 ug poly(dl-dC), 0.1 ug herring sperm DNA, 1 mM DTT, 100 mM KC1 and 10 ug nuclear extract protein. The mixture was pre-incubated at room temperature for 15 min to avoid non-specific protein-DNA interactions.
In competition experiments excess unlabeled DNA or antisera against c-Jun, JunB, c-Fos and Fra-1 (I ug) were added. Then 1 ill [y^PJdATP end-labeled DNA probe (50 000-100 000 c.p.m., -50 fmol) was added to the reaction mixture to a final volume of 15 ul. The binding assay was performed at room temperature for 15 min. Proteins were separated by SDS-PAGE at 120 V for 2 h at 4°C in TGE buffer (50 mM Tris, 380 mM glycine, 2 mM EDTA). The gel was dried and autoradiographed
Northern blot analysis
Isolation of total RNA was performed by the guanidinium thiocyanate method as described by Chomczynski and Sacchi (33) . RNA samples (20 ug) were denatured with 2.2 M formaldehyde, 50% formamide and 1X MOPS buffer, pH 7.0 (20 mM 3-W-morpholinopropane sulfonic acid, 5 mM sodium acetate, 1 mM EDTA) by heating for 3 min at 70°C. After electrophoresis in a 1% agarose gel containing 2.2 M formaldehyde RNA was transferred to a nylon membrane (Hybond N; Amersham Buchler) by capillary blotting in 20X SSC (3 M NaCI, 0.3 M sodium citrate buffer, pH 7.0). RNA was covalently bound to the membrane by UV irradiation and then pre-hybridized in 6X SSC, 50% deionized formamide, I Ox Denhardt's solution and 0.5% SDS at 44°C for 24 h. Hybridization was performed at 44°C for 48 h using a plasmid containing c-jun cDNA (34) . The probes were labeled by the random primer method using [a-32 P]dCTP (35) . Washing of the membrane was carried out twice in 2X SSC, 0.1% SDS at 50°C for 20 min. The membrane was exposed for 1-7 days at -70°C to Kodak XAR-5 film with intensifying screens. For densitometry the system and Hyper-CAM software of Cybertech (Berlin, Germany) were used.
Western blot analysis
Nuclear extracts (100 ug protein) were separated by SDS-PAGE (10% polyacrylamide) according to Laemmli (36) and transferred to Immobilion PVDF membranes (Millipore, Bedford, MA) by electroblotting for 30 min at 200 mA. After blocking of non-specific binding sites with phosphatebuffered saline (PBS) containing Tween (0.05%) and milk powder (5%) for I h the membrane was washed with PBS/Tween and then incubated overnight with primary rabbit polyclonal antibodies against either c-Jun, JunB or Fra-1 (0.1 ug/ul) at a 1:250 dilution. The membrane was washed again in PBS/ Tween and incubated for 15 min with secondary horseradish peroxidaselabeled swine anti-rabbit IgG antibodies at a 1:10 000 dilution. After an additional washing step antibody binding was visualized by enhanced chemiluminescence according to the protocol of Amersham Buchler (Braunschweig, Germany). Densitometry was carried out using the Intelligent Quantifier of Bio Image (Millipore, Bedford, MA).
Statistics
For the assessment of treatment effects in Table I analysis of variance for log-transformed data was used. Otherwise Student's /-test was applied.
Results
Hepatocyte system
Treatment of primary hepatocyte cultures with TCDD and mitogenic stimulation by EGF are described in Figure 1 . Conditions could be defined leading to either positive or negative modulation of EGF-stimulated DNA synthesis by TCDD (Table I , experimental groups 1 and 4 respectively). In the presence of EE 10~1 2 M TCDD acted as a co-mitogen (group 1). At 10" 9 M TCDD the stimulating effect was abolished. In the absence of EE 10" 12 M TCDD was without effect, but 10~9 M TCDD significantly inhibited DNA synthesis (mitoinhibition, group 4). Analysis of variance revealed that the effects of TCDD concentration in group 1 versus 2 and in group 4 versus 3 were highly significant {P < 0.01). The effect of EE treatment was also significant and independent TCDD EGF 170 kDa - Table II ).
of the effects of TCDD (not shown). Under the conditions of experimental group 4 the EGF receptor level was also studied to exclude possible receptor down-regulation by the 21 h TCDD pre-treatment. However, receptor activity (determined as autophosphorylation after addition of EGF) appeared to be unaffected by short-term TCDD treatment (Figure 2) .
'Early genes' of the junJfos family and the corresponding proteins were studied as members of the EGF signaling cascade under conditions of positive and negative modulation of DNA "Conditions and experimental groups 1 and 4 were those described in Table I . c-Jun/Fra-1 levels were detected 2 h after the addition of EGF. b Protein levels determined in nuclear extracts of respective controls (-TCDD) were taken as 100%. thinylestradiol (20 iiM). d Data represent means + SD of four experiments. e Significandy different from 100% controls (P < 0.05).
synthesis (Table I , experimental groups 1 and 4 respectively). Northern blot analysis revealed that c-jun mRNA was moderately increased (~2.5-fold, n = 3) by a 21 h treatment with 10~1 2 M TCDD, in line with findings in mouse hepatoma cell cultures (37) . c-jun mRNA was also increased (~2.7-fold, n = 3) at 2 h after addition of EGF to controls (-TCDD), in agreement with others (38) . However, combined treatment with both ID" 12 M TCDD and EGF did not further increase c-jun expression. Furthermore, c-jun mRNA was not decreased by treatment with 10" 9 M TCDD (data not shown). Jun/Fos proteins were studied in nuclear extracts 2 h after addition of EGF ( Figure 3 and Table II ). In the presence of EE 10" 12 M TCDD increased c-Jun ( Figure 3A) , while in the absence of EE 10~9 M TCDD decreased c-Jun (Figure 3B ), in agreement with positive or negative modulation of EGF-stimulated DNA synthesis (Table I) . To substantiate these findings DNA binding of Jun/Fos proteins (AP-1 activity) was also determined by gel mobility shift analysis. As shown in Figure 4 , AP-1 activity was decreased by 10~9 M TCDD (-EE). (Increased AP-1 activity was not detectable after treatment with 10~1 2 M TCDD+EE, probably due to the small effect.) AP-1 complexes were abolished in the presence of an excess of unlabeled oligonucleotide. Interestingly, the AP-1 complexes appeared to contain c-Jun and Fra-1, while the presence of JunB and c-Fos could not be demonstrated. Under the conditions of group 4 Fra-1 was significantly increased in nuclear extracts ( Figure 3C and Table II) . It can also be seen that treatment with EE clearly increased levels of c-Jun (Figure 3B ), Fra-1 ( Figure 3C ) and JunB (not shown).
WB-F344 cell system
When subconfluent cultures of WB cells were treated with 10"
9 M TCDD for 44 h dT incorporation appeared to be increased 3-fold in comparison with untreated controls (Table  HI) . In controls dT incorporation decreased with time, probably due to progressing high density growth arrest, while in TCDD-treated cells dT incorporation remained constant. In agreement with dT incorporation the nuclear labeling index determined by BrdU incorporation was increased 2-fold at 40 h. Three experiments showed 5.0 ± 0.3% and 12.0 ± 0.8% BrdU-positive nuclei at 40 h in untreated controls and cultures treated with 10~9 M TCDD respectively. Dose dependency of the TCDD effects was studied at 44 h ( Figure 5 ). Note that in untreated controls (C) dT incorporation reflects growth-arrested cultures. Hence the data suggest that TCDD dose-dependently inhibits growth arrest. This response appeared to be maximal at 10~1 0 M TCDD, a concentration which led to a marked increase in CYP1A activity, as reflected by EROD activity in cell homogenates.
Discussion
Modulation of growth homeostasis by TCDD has been studied in primary hepatocyte cultures and WB-F344 cells. These models may be useful to elucidate the interactions of the Ah receptor with intracellular growth factor signaling cascades. Hepatocyte system Previous studies demonstrated either positive or negative modulation of EGF-stimulated DNA synthesis in hepatocyte cultures (12) (13) (14) . Both effects have been shown to be dependent upon expression of the high affinity Ah receptor in mouse hepatocyte cultures (14) . The present studies were carried out to better define the conditions leading to positive and negative modulation of DNA synthesis. TCDD effects were studied under serum-free conditions both in the presence and absence of estrogens such as EE, which are known to increase EGF signaling both in vitro (13, 17, 18) and in vivo (39) . In the presence of EE 10~1 2 M TCDD led to positive modulation of EGF-stimulated DNA synthesis (Table I ). This effect, although small, was highly significant (P < 0.01) and may be related to stimulation of DNA synthesis in periportal hepatocytes by in vivo treatment with TCDD (15) . In the absence of EE 10~9 M TCDD negatively modulated EGF-stimulated DNA synthesis. Mitoinhibitory conditions may be more relevant to liver tumor promotion in vivo, since they may facilitate selective clonal expansion of toxin-resistant, pre-neoplastic hepatocytes (40). However, the underlying mechanisms are still under debate (41, 42) .
Under the conditions of positive and negative modulation of DNA synthesis by TCDD the response of 'early genes' of the junlfos family and the corresponding proteins were studied. In agreement with DNA synthesis data c-Jun protein levels were increased or decreased in nuclear extracts of hepatocytes (Table  II , groups 1 and 4 respectively). Furthermore, gel retardation analysis revealed that DNA binding of Jun/Fos proteins, including c-Jun and Fra-1, was decreased under conditions of mitoinhibition, while the level of Fra-1 was increased in nuclear extracts. Interestingly, induction of Fra-1 expression has been reported to lower the transactivation potential of AP-1 complexes (43) . c-jun mRNA was unaffected and c-Jun protein decreased in nuclear extracts after treatment with 10" 9 M TCDD, suggesting that TCDD exerts its effects mostly through an alteration in protein phosphokinases/phosphatases, similar to TCDD effects in other studies (44, 45) .
WB-F344 cell system WB cells, generated by Grisham (46), appear to be unique among epithelial cell lines in that they express inducible CYP1A1 (23) . This response was not observed in other epithelial cell lines (47) . Epithelial cell lines or 'oval cells' may be considered as precursors in the lineage from stem cells to differentiated hepatocytes or bile duct cells (48) . They are not transformed. Addition of EGF leads to a small increase (-10%) in DNA synthesis under our conditions (not shown). Therefore, the influence of TCDD was studied in the absence of EGF. TCDD was without effect on dT incorporation in logarithmically growing cells. However, when added to confluent cells TCDD appeared to inhibit high density growth arrest. While rapidly decreasing in controls, dT incorporation remained constant in the presence of TCDD. Hence, in 44 h TCDD-treated cell cultures DNA synthesis was increased 3-fold in comparison with controls. Inhibition of high density growth arrest was also found in human squamous carcinoma cells (49) . We are currently investigating whether growth factor signaling pathways are endogenously stimulated in WB cells. We also intend to investigate the TCDD response of preneoplastic hepatocytes (50) . In vivo investigations using an initiation/promotion model of hepatocarcinogenesis indicated that TCDD moderately increased DNA synthesis in pre-neoplastic hepatocytes (51) and strongly inhibited apoptosis (52) . Both processes contribute to clonal expansion of pre-neoplastic hepatocytes and represent the basis for tumor promotion (53) . It remains to be shown whether inhibition of high density growth arrest, as demonstrated in WB cells, is related to processes responsible for increased DNA synthesis in pre-neoplastic hepatocytes.
Elucidation of the Ah receptor/Arnt mechanism has been a milestone in Ah receptor-mediated CYP1A1 induction (1-7). However, at present the mechanisms linking Ah receptor activation with toxic reactions to TCDD are largely unknown. Elucidation of these mechanisms remains a major challenge for the future. TCDD effects may be explained by, for example: (i) transcriptional activation of genes involved in growth homeostasis; (ii) mRNA stabilization, as in the case of TGFa (54, 55) ; (iii) stimulation of Ah receptor-mediated activation of protein phosphokinases in the absence of transcriptional activation (45) . Cellular models such as the WB-F344 cell system may be useful to meet this challenge.
